SCHEMBL1055867

SCHEMBL1055867

N[C@@H](Cc1onc(O)c1Cl)C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 6/20 0.50
GRIA3 P42263 6/20 0.50
GRIA2 P42262 6/20 0.50
GRIA4 P48058 5/20 0.50
GRIK1 P39086 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C19 P33261 1/20 0.50
SLC7A5 Q01650 1/20 0.39
USP2 O75604 2/20 0.38
RGS12 O14924 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
PKM P14618 1/20 0.38
ALOX15 P16050 1/20 0.38
NFKB1 P19838 1/20 0.38
CASP1 P29466 1/20 0.38
BRCA1 P38398 1/20 0.38
THPO P40225 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1055865 1.00 GRIA1 (0.50) GRIA1GRIA3GRIA2GRIA4GRIK1
SCHEMBL5280594 0.80 GRIA1 (0.50) GRIA1GRIA3GRIA2GRIA4GRIK1
SCHEMBL12648359 0.80 GRIA1 (0.49) GRIA1GRIA3GRIA2GRIA4GRIK1
SCHEMBL5281708 0.80 GRIA1 (0.49) GRIA1GRIA3GRIA2GRIA4GRIK1
SCHEMBL11362942 0.73 PTGS2 (0.36)
(R,S)-Ampa SCHEMBL2458874 0.70 GRIA1 (0.69) GRIA1GRIA3GRIA2GRIA4GRIK1
(S)-Ampa SCHEMBL667915 0.70 GRIA1 (0.69) GRIA1GRIA3GRIA2GRIA4GRIK1
SCHEMBL7163361 0.70 GRIA1 (0.56) GRIA1GRIA3GRIA2GRIA4GRIK1
SCHEMBL7163355 0.70 GRIA1 (0.56) GRIA1GRIA3GRIA2GRIA4GRIK1
(R,S)-Ampa SCHEMBL68799 0.70 GRIA1 (0.69) GRIA1GRIA3GRIA2GRIA4GRIK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2254568-B1 COMPOUND THAT ACTIVATES AN AMPA/KAINATE TYPE RECEPTOR FOR TREATING HYPOGLYCEMIA UNIV MIAMI (US) 2017-06-07 EP claimed
US-20150105436-A1 Methods and Assays for Detecting and Treating Hypoglycemia BIOCRINE AB (SE) 2015-04-16 US claimed
US-20130217738-A1 Methods and Assays for Detecting and Treating Hypoglycemia BIOCRINE AB (SE) 2013-08-22 US claimed
US-20110021584-A1 Methods and Assays for Detecting and Treating Hypoglycemia UNIVERSITY OF MIAMI (US) 2011-01-27 US claimed
EP-2254568-A2 METHODS AND ASSAYS FOR DETECTING AND TREATING HYPOGLYCEMIA University of Miami (US) 2010-12-01 EP claimed
WO-2009114718-A2 METHODS AND ASSAYS FOR DETECTING AND TREATING HYPOGLYCEMIA UNIVERSITY OF MIAMI (US) 2009-09-17 WO claimed
EP-2254568-B1 COMPOUND THAT ACTIVATES AN AMPA/KAINATE TYPE RECEPTOR FOR TREATING HYPOGLYCEMIA UNIV MIAMI (US) 2017-06-07 EP disclosed
US-20150105436-A1 Methods and Assays for Detecting and Treating Hypoglycemia BIOCRINE AB (SE) 2015-04-16 US disclosed
US-20130217738-A1 Methods and Assays for Detecting and Treating Hypoglycemia BIOCRINE AB (SE) 2013-08-22 US disclosed
US-8466185-B2 Methods and assays for detecting and treating hypoglycemia BIOCRINE AB (SE) 2013-06-18 US disclosed
US-20110021584-A1 Methods and Assays for Detecting and Treating Hypoglycemia UNIVERSITY OF MIAMI (US) 2011-01-27 US disclosed
EP-2254568-A2 METHODS AND ASSAYS FOR DETECTING AND TREATING HYPOGLYCEMIA University of Miami (US) 2010-12-01 EP disclosed
WO-2009114718-A2 METHODS AND ASSAYS FOR DETECTING AND TREATING HYPOGLYCEMIA UNIVERSITY OF MIAMI (US) 2009-09-17 WO disclosed